Machine learning in medicine

Machine Learning in Medicine

Volumn 9789400758247, Issue , 2013, Pages 1-265

  Cleophas, Ton J ^a   Zwinderman, Aeilko H ^b  

^a European College of Pharmaceutical Medicine   (France)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL INTELLIGENCE; CLINICAL RESEARCH; CLUSTER ANALYSIS; DISCRIMINANT ANALYSIS; MARKETING;

APPLIED SCIENCE; CLINICAL TRIAL; COMPUTER SCIENTISTS; DATA FILES; MARKETING RESEARCH; OPERATIONAL RESEARCH; RANDOMIZATION PROCESS;

LEARNING SYSTEMS;

EID: 84933052803     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-5824-7     Document Type: Book

References (182)

1. O'Connor B (2012) Statistics versus machine learning, fight. http://brenocon.com/blog/2008/12. Accessed 25 Aug. 2012
2. Yates F (1952) George Udney Yule. Obit Not R Soc Stat 8:308
3. Chatfield C (2004) The analysis of time series, an introduction, 6th edn. Chapman & Hall, New York
4. Getis A (2007) Reflections on autocorrelations. Reg Sci Urban Econ J 37:491-496
5. Douglas AS, Rawles JM, Al-Sayer H, Allan TM (1991) Seasonality of disease in Kuwait. Lancet 337:1393-1397
6. Hancox JG, Sheridan SC, Feldman SR, Fleischer AB (2004) Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. Int J Dermatol 43:8-11
7. Whitehead BS (2004) Winter seasonal affective disorder: a global biocultural perspective. ANT (Actor-Network Theory), 570. Accessed 18 Dec. 2012
8. Gonzalez DA, Victora CG, Goncalves H (2008) The effects of season at time of birth on asthma and pneumonia and adulthood in a birth cohort in southern Brazil. Cad Saude Publica 24:1089-1102
9. Parslow RA, Jorm AF, Butterworth P, Jacomb PA, Rodgers B (2004) An examination of seasonality experienced by Australians living in a continental temperate climate zone. J Affect Disord 80:181-190
10. Kelly GS (2005) Seasonal variations of selected cardiovascular risk factors. Altern Med Rev 10:307-320
11. Sung KC (2006) Seasonal variation of C-reactive protein in apparently healthy Koreans. Int J Cardiol 107:338-342
12. Rudnick AR, Rumley A, Lowe GD, Strachan DP (2007) Diurnal seasonal and blood processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45 year old population. Circulation 115:996-1003
13. Fishman DN (2007) Seasonality of infectious diseases. Annu Rev Public Health 28:127-143
14. Lofgren E, Fefferman NH, Naumov YN, Gorski J, Naumova EN (2007) Infuenza seasonality, underlying causes and modeling theories. J Virol 8:5429-5436
15. Chiriboga DE, Ma Y, Li W, Stanek EJ, Hebert JR, Merriam PA, Rawson ES, Ockene IS (2009) Seasonal and sex variation of high-sensitivity C-reactive protein in healthy adults; a longitudinal study. Clin Chem 55:313-321
16. Mianowski B, Fendler W, Szadkowska A, Baranowska A, Grzelak E, Sadon J, Hkeenan H, Mlynarski W (2011) HbA1c levels in schoolchildren with type 1 diabetes are seasonally variable and dependent on weather conditions. Diabetologia 54:749-756
17. SPSS Statistical Software (2012) www.spss.com. Accessed 28 Feb. 2012
18. Cleophas TJ, Zwinderman AH (2012) Time series. In: Statistics applied to clinical studies, 5th edn. Springer, New York, pp 687-693
19. Halberg F, Corneleissen G, Otsuka K, Fiser B, Mitsutake G, Wendt HW, Johnson P, Gigolashvili M, Breus T, Sonkowsky R, Chibisov SM, Katinas G, Diegelova J, Dusek J, Singh RB, Berri BL, Schwartzkopff O (2005) Incidence of sudden cardiac death, myocardial infarction and far- and near-transyears. Biomed Pharmacother 59(Suppl 1):S239-S261
20. De Andrade D, Hirata R DC, Sandrini F, Largura A, Hirata MH Uric acid biorhythm, a feature of longterm variation in a clinical database. Clin Chem Lab Med. doi:10.1515/cclm-2011-0150. Published Online 02/03/2012
21. Ferguson JC (1964) Multi-variable curve interpolation. JACM 11:221-228
22. Birkhof F, De Boor R (1964) Piecewise polynomial interpretation and approximation. In: Proceedings of general motors symposium of 1964. Detroit, MI, pp 164-190
23. Cleophas TJ, Zwinderman AH (2009) Monte Carlo methods. In: Statistics applied to clinical trials, 4th edn. Springer, Dordrecht, pp 479-485
24. SPSS Statistical Software. www.spss.com. Accessed 3 Feb. 2012
25. Stata Statistical Software. www.stat.com. Accessed 3 Feb. 2012
26. Box-Cox normality plot. http://itl.nist.gov/div898/handbook/eda/section3/eda336.htm. Accessed 18 Dec. 2012
27. Additive regression and transformation using ace or avas. http://pinard.progiciels-bpi.ca/LibR/library/Hmisc/html/transace.html. Accessed 18 Dec. 2012
28. Anonymous. Free statistics and forecasting software, Box-Cox Normality Plot Calculator. www.essa.net/rwasp-boxcoxnorm.wasp/. Accessed 3 Feb. 2012
29. Cleophas TJ, Zwinderman AH (2009) Curvilinear regression. In: Statistics applied to clinical trials, 4th edn. Springer, Dordrecht, pp 185-196
30. Cleophas TJ, Zwinderman AH (2009) Regression analysis with Laplace transformations. In: Statistics applied to clinical trials, 4th edn. Springer, Dordrecht, pp 213-216
31. Sheiner LB, Beal SL (1983) Evaluation of methods for estimation of population pharmacokinetic parameters. J Pharmacokinet Pharmacodyn 11:303-319
32. Cubic Spline for Excel. www.srs1software.com/download.htm#pline. Accessed 18 Dec. 2012
33. Lambda-calculus. http://en. wikipedia.org/wiki/lambda-calculus. Accessed 18 Dec. 2012
34. Hastie T, Tibshirani R (1990) Generalized additive models. Chapman & Hall, London
35. Generalized additive model. http://en. wikipedia.org/wiki/generalized-additive-model. Accessed 18 Dec. 2012
36. Local regression. http://en. wikidepia.org/wiki/Local-regression. Accessed 18 Dec. 2012
37. Akaike information criterion. http://en. wikipedia.org/wiki/Akaike-information-criterion. Accessed 18 Dec. 2012
38. WWW.SPSS.COM
39. Stergiou C, Siganos D. Neural networks. www.doc.ic.ac.uk
40. Andrew AM (2004) Work of Warren McCulloch. Kybernetes 33:141-146
41. Rosenblatt F (1962) Principles of neurodynamics: perceptrons and the theory of brain mechanisms. Spartan, New York
42. Minsky MA (1974) Framework for representing knowledge. Technical report Massachusetts Institute of Technology, AIM-306, Cambridge, MA, USA
43. Rumbelhart DE, Hinton GE, Williams RJ (1986) Learning representations by back-propagating errors. Nature 323:533-536
44. Simpson JH, McArdle C, Pauson AW, Hume P, Turkes A, Griffiths K (1995) A non-invasive test for the pre-cancerous breast. Eur J Cancer 31A: 1768-1772
45. Naguib RN, Adams AE, Horne CH, Angus B, Sherbet GV, Lennard TW (1996) The detection of nodal metastasis in breast cancer using neural networks. Physiol Meas 17:297-303
46. Sherman ME, Schiffman MH, Mango LJ, Kelly D, Acosta D, Cason Z, Elgert P, Zaleski S, Scot DR, Kurman R, Stoler M, Lorincz AT (1997) Evaluation of PAPNET testing as an ancillary tool to clarify the status of the atypical cervical smear. Mod Pathol 10:564-567
47. Mango LJ, Valente PT (1998) Neural networks assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. Acta Cytol 42:227-232
48. Doornewaard H, Van Der Schouw YT, Van Der Graaf Y, Bos AB, Habbema JD, Van Den Tweel JG (1999) The diagnostic value of computer assisted primary smear screening: a longitudinal cohort study. Mod Pathol 12:995-1000
49. Prismatic Project Management Team (1999) Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. Lancet 353:1381-1385
50. Finne P, Finne R, Auvinen A, Juusela H, Aro J, Maattanen L, Hakama M, Ranniko S, Tammela TL, Stenman U (2000) Predicting the outcome of prostate biopsy in screen positive men by a multilayer perceptron network. Urology 56:418-422
51. Gamito EJ, Stone NN, Batuello JT, Crawford ED (2000) Use of artificial neural networks in the clinical staging of prostate cancer. Tech Urol 6:60-63
52. Bugliosi R, Tribalto M, Avvisati G, Boccardoro M, De Martinis C, Friera R, Mandelli F, Pileri A, Papa G (1994) Classification of patients affected by multiple myeloma using neural network software. Eur J Haematol 52:182-183
53. Kothari R, Cualing H, Balachander T (1996) Neural network analysis of flow cytometry immunophenotype data. IEEE Biomed Eng 43:803-810
54. Glas JO, Reddick WE (1998) Hybrid artifiucial neural network segmentation and classification of dynamic contrast enhanced MR imaging of osteosarcoma. Magn Reson Imaging 16:1075-1083
55. Bryce TJ, Dewhirst MW, Floyd CE, Hars V, Brizel DM (1998) Artificial neural networks of survival in patients treated with irradiation with and without concurrent chemotherapy for advanced carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 41:339-345
56. Stock A, Rogers MS, Li A, Chang AM (1994) Use of neural networks for hypothesis generation in fetal surveillance. Baillieres Clin Obstet Gynaecol 8:533-548
57. Si Y, Gotman J, Pasupathy A, Flanagan D, Rosenblatt B, Gottesman R (1998) An expert system for EEG monitoring in the pediatric intensive care. Electroencephalogr Clin Neurophysiol 106:488-500
58. Zernikow B, Holtmannspotter K, Michel E, Theilhaber M, Pielemeier W, Hennecke KH (1998) Artificial neural network for predicting intracranial haemorrhage in preterm neonates. Acta Paediatr 87:969-975
59. Zernikow B, Holtmannspotter K, Michel E, Hornschuh F, Groote K, Hennecke KH (1999) Predicting length of stay in preterm neonates. Eur J Pediatr 158:59-62
60. Eftekbar B, Mohammad K, Ardebilli HE, Ghodsi M, Ketabchi E (2005) Comparison of artificial neural network and regression models for prediction of mortality in head trauma based on clinical data. BMC Med Inf Decis Mak 5:3-9
61. Selker HP, Griffith JL, Patil S, Long WJ, D'Agostino RB (1995) A comparison of performance of mathematical predictive methods for medical diagnosis: identifying acute cardiac ischemia among emergency department patients. J Investig Med 43:468-476
62. Baxt WG, Skora J (1996) Prospective validation of artificial neural network trained to identify acute myocardial infarction. Lancet 347:12-15
63. Ellenius J, Groth T, Lindahl B (1997) Neural network of biochemical markers for early assessment of acute myocardial infarction. Stud Health Technol Inform 43:382-385
64. Goodenday LS, Cios KJ, Shin L (1997) Identifying coronary stenosis using an image recognition neural network. IEEE Eng Med Bio Mag 16:139-144
65. Polak MJ, Zhou SH, Rautaharju PM, Armstrong WW, Chaitman BR (1997) Using automated analysis of resting twelve lead ECG to identify patients at risk of developing transient myocardial ischaemia. Physiol Meas 18:317-325
66. Lindahl D, Toft J, Hesse B, Palmer J, Ali S, Lundin A, Edenbrandt L (2000) Scandinavian test of artificial neural network for classification of myocardial perfusion images. Clin Physiol 20:253-261
67. Patil N, Smith TJ. Neural network analysis speeds disease risk predictions, innovative clinical models transform cardiovascular assessment algorithms. In: Scientific computing 2009, Rockaway NJ, p 07866. www.scientificcomputing.com. Accessed 18 Dec. 2012
68. Queralto JM, Torres J, Guinot M (1999) Neural networks for the biochemical prediction of bone mass. Clin Chem Lab Med 37:831-838
69. Papik K, Molnar B, Fedorczak P, Schaefer R, Lang F, Sreter L, Feher J, Tulassay Z (1999) Automated prozone effect detection in ferritin homogenous assays using neural networks. Clin Chem Lab Med 37:471-476
70. Mitchell D, Strydom NB, Van Graan CH, Van Der Walt H (1971) Human surface area: comparison of the du Bois formula with direct photometric measurement. Eur J Physiol 325:188-190
71. Haycock GB, Schwarz GJ, Wisotsky DH (1978) Body surface area calculated from the height and weight. J Pediatr 93:62-66
72. Atiqi R, Van Iersel C, Cleophas TJ (2009) Accuracy of quantitative diagnostic tests. Int J Clin Pharmacol Ther 47:153-159
73. Heden B, Edenbrandt L, Hasity WK, Pahlm O (1994) Artificial neural networks for electrocardiographic diagnosis of healed myocardial infarction. Am J Cardiol 74:5-8
74. Redding NJ, Kowalczyk A, Downs T (1993) Constructive higher order network algorithms that is polynomial time. Neural Netw 6:997-1010
75. Sperduti A, Starita A (1993) Speed up learning and network optimization with extended back propagation. Neural Netw 6:365-383
76. Wnek J, Michalski RS (1994) Hypothesis driven constructive induction in AQ17-HCI: a method and experiments. Mach Learn 14:139-168
77. Lytton WW (2002) From artificial neural network to realistic neural network, Chapter 14. In: From computer to brain. Springer, New York, pp 259-268
78. Franke R (1982) Scattered data interpolation: tests of some methods. Math Comput 38:181-200
79. Rumelhart DE, Hinton GE, Williams RJ (1986) Learning representations by back propagating errors. Nature 323:533-536
80. Xie T, Yu H, Wilamowski B (2011) Comparison between traditional neural networks, and radial basis function networks. Institute Electricity Electronics Engineers, New York, 978-1-4244-9312-8/11
81. Davies JR, Coggeshall S V, Jones RD, Schutzer D (1995) Intelligent security systems. In: Freedman RS et al (eds) Artificial intelligence in the capital markets. Irwin, Chicago. ISBN 1-55738-811-3
82. Mountrakis G, Zhuang W (2012) Integrating local and global error statistics for multiscale RBF networks training. PLOS. www.plosone.org/article/info%3A doi%2F10.1371. Accessed 21 Aug. 2012
83. Balasubramanie P, Florence ML (2009) Application of radial basis network model for HIV/AIDS regimen specifications. J Comput 1:136-140
84. Kestler HA, Schwenker F, Palm G (2012) RBF network classification of ECGs as a potential marker for sudden cardiac death. www.researchgate.net/publicatrion/29528327. Accessed 21 Aug. 2012
85. Hartman EJ, Keeler JD, Kowalski JM (1990) Layered neural networks with Gaussian hidden units as universal approximations. Neural Comput 2:210-215
86. Gallegos FJ, Gomez ME, Lopez JL, Cruz R (2009) Rank m-type radial basis function neural network for Pap smear microscopic image classification. Apeiron 16:542-554
87. SPSS Statistical Software. www.spss.com
88. Cleophas TF, Cleophas TJ (2011) Artificial intelligence for diagnostic purposes; principles, procedures, and limitations. Clin Chem Lab Med 48:159-165
89. Mitchell D, Strydom NB, Van Graan CH, Van Der Walt H (1971) Human surface area: comparison of the du Bois formula with direct photometric measurement. Eur J Physiol 325:188-190
90. Haycock GB, Schwarz GJ, Wisotsky DH (1978) Body surface area calculated from the height and weight. J Pediatr 93:62-66
91. Atiqi R, Van Iersel C, Cleophas TJ (2009) Accuracy of quantitative diagnostic tests. Int J Clin Pharmacol Ther 47:153-159
92. Eftekbar B, Mohammad K, Ardebilli HE, Ghodsi M, Ketabchi E (2005) Comparison of artificial neural network and regression models for prediction of mortality in head trauma based on clinical data. BMC Med Inf Decis Mak 5:3-9
93. Baxt WG, Skora J (1996) Prospective validation of artificial neural network trained to identify acute myocardial infarction. Lancet 347:12-15
94. Heden B, Edenbrandt L, Hasity WK, Pahlm O (1994) Artificial neural networks for electrocardiographic diagnosis of healed myocardial infarction. Am J Cardiol 74:5-8
95. Redding NJ, Kowalczyk A, Downs T (1993) Constructive higher order network algorithms that is polynomial time. Neural Netw 6:997-1010
96. Sperduti A, Starita A (1993) Speed up learning and network optimization with extended back propagation. Neural Netw 6:365-383
97. Wnek J, Michalski RS (1994) Hypothesis driven constructive induction in AQ17-HCI: a method and experiments. Mach Learn 14:139-168
98. Lytton WW (2002) From artificial neural network to realistic neural network, Chapter 14. In: From computer to brain. Springer, New York, pp 259-268
99. Barthelemew DJ (1995) Spearman and the origin and development of factor analysis. Br J Math Stat Psychol 48:211-220
100. Anonymous (2012) SPSS statistical software version 18.0. Module dimension reduction, factor analysis, Online Help. www.spss.com. Accessed 29 Apr. 2012
101. Anonymous (2012) Factor analysis. Wikipedia, the free encyclopedia, Accessed 25 Apr. 2012
102. Meng J (2012) Uncover cooperative gene regulations by microRNAs and transcription factors in glioblastoma using a nonnegative hybrid factor. www.cmsworldwide.com?ICASS2011. Accessed 29 Apr. 2012
103. Hochreiter S, Clevert DA, Obermayer K (2006) A new summarization method for affymetrix probe level data. Bioinformatics 22:943-949
104. Solyanik GI (2010) Multifactorial nature of tumor drug resistance. Exp Oncol 32:181-185
105. Tsao DA, Chang HJ, Hsiung SK, Huang SE, Chang MS, Chiu HH, Chen YF, Cheng TL, Shiu-Ru L (2010) Gene expression profiles les for predicting the efficacy of the anticancer drug 5-fluorouracil in breast cancer. DNA Cell Biol 29:285-293
106. Latan MS, Laddha NC, Latani J, Imran MJ, Begum R, Misra A (2012) Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis. Drug Deliv Transl Res 2:129-141
107. National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland. Enhancing HIV vaccine efficacy in high-risk drug users. Release data Jan 6 2003, RFA Number DA-03-002
108. Alsford S, Eckert S, Baker N, Glover L, Sanchez-Flores A, Leung KF, Turner DJ, Field MC, Berriman M, Horn D (2012) High throughput decoding of antitrypanosomal drug efficacy and resistance. Nature. doi: 10.1038/nature10771
109. Sibson R (1973) An optimally efficient algorithm for a single-link cluster method. Comput J 16:30-34
110. Defays D (1977) An efficient algorithm for a complete link cluster method. Comput J 20:364-366
111. Anonymous (2012) Cluster analysis. http://en. wikipedia.org/Clustert-analysis. Accessed 12 July 2012
112. Anonymous (2012) Sequence clustering. http://en. wikipedia.org/wiki/Sequence-analysis. Accessed 12 July 2012
113. Kim HK, Choi IJ, Kim HS, Oshima A, Michalowski A, Green JE (2011) A gene expression signature of acquired chemoresistance to cisplatinum and fluorouracil combination chemotherapy in gastric cancer patients. PLoS One 18:e16694
114. Yeh ST (2012) Clinical adverse event data analysis and visualization. Smith Kline Datafile, Accessed 10 July 2012
115. Bychowiec B, Piskorski J, Stanislawska K, Dziarmaga M, Mineczykowski A, Wykretowicz A, Wysocki H (2010) An exploratory clustering study of rare adverse events in drug deluting stent patients. Comput Methods Sci Technol 16:5-11
116. Xu D, Redamn-Furey N (2007) Statistical cluster analysis of pharmaceutical solvents. Int J Pharm 339:175-188
117. Hawwa A, Millership JS, Collier PS, McCarthy A, Dempsey S, Cairns C, McElnay JC (2009) Development of objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leucemia. Eur J Clin Pharm 65:1105-1112
118. SPSS statistical software (2012) www.spss.com. Accessed 12 July 2012
119. Tsao DA, Chang HJ, Hsiung SK, Huang SE, Chang MS, Chiu HH, Chen YF, Cheng TL, Shiu-Ru L (2010) Gene expression profiles for predicting the efficacy of the anticancer drug 5-fluorouracil in breast cancer. DNA Cell Biol 29:285-293
120. Latan MS, Laddha NC, Latani J, Imran MJ, Begum R, Misra A (2012) Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis. Drug Deliv Transl Res 2:129-141
121. Albertin PS (1999) Longitudinal data analysis (repeated measures) in clinical trials. Stat Med 18:2863-2870
122. Yang X, Shen Q, Xu H, Shoptaw S (2007) Functional regression analysis using an F test for ongitudinal data with large numbers of repeated measures. Stat Med 26:1552-1566
123. Sverdlov L (2001) The fastclus procedure as an effective way to analyze clinical data. In: SUGI proceedings 26, paper 224, Long Beach, CA
124. Barthelemew DJ (1995) Spearman and the origin and development of factor analysis. Br J Math Stat Psychol 48:211-220
125. Anonymous (2012) SPSS Statistical Software version 18.0. Module dimension reduction, factor analysis, Online Help. www.spss.com. Accessed 29 Apr. 2012
126. Wold H (1966) Estimation of principle components and related models by iterative least squares. In: Krishnaiah PR (ed) Multivariate analysis. Academic, New York, pp 391-420
127. Anonymous (2012) Factor analysis. Wikipedia, the free encyclopedia. Accessed 25 Apr. 2012
128. Anonymous (2012) Partial least squares regression. http://en. wikipedia.org/wiki/Partial-least-squares-regression. Accessed 13 Apr. 2012
129. Tenenhaus M, Vinzi VE, Chatelin YM, Lauro C (2005) PLS path modeling. Comput Stat Data Anal 48:159-205
130. Meng J (2012) Uncover cooperative gene regulations by microRNAs and transcription factors in glioblastoma using a nonnegative hybrid factor. www.cmsworldwide.com?ICASS2011. Accessed 29 Apr. 2012
131. Hochreiter S, Clevert DA, Obermayer K (2006) A new summarization method for affymetrix probe level data. Bioinformatics 22:943-949
132. Bastien T (2004) PLS-Cox model: application to gene expression. COMPSTAT 2004; section: Partial Least Squares
133. Li X, Gill R, Cooper NG, Yoo JK, Datta S (2011) Modeling microRNA-mRNA interactions using pls regression in human colon cancer. BMC Med Genomics 4:44
134. Anonymous R (2012) Statistical software. Partial least squares, a free statistics and forecasting software. www.wessa.net/rwasp. Accessed 25 May 2012
135. Guinot C, Latreille J, Tenehaus M (2001) PLS path modeling and multiple table analysis. Application to cosmetic habits of women in Ile de France. Chem Intell Lab Syst 58:247-259
136. Cole DA, Maxwell SE, Arvey R, Salas E (1994) How the power of MANOVA can both increase and decrease as a function of the intercorrelations among the dependent variables. Psychol Bull 115:465-474
137. Fisher RA. The design of experiments. McMillan, London (First edition 1935; Ninth edition 1971)
138. Klecka WR (1973) Discriminant analysis. Google books, 1973, Google, Accessed 08 Jan 2012
139. Anonymous. Discriminant analysis. www.wikidepia.org/wiki/Discrimination-function-analysis
140. Ogah DM, Momoh OM, Dim NI (2011) Application of canonical discriminant analysis for assessment of genetic variation in Muscovy duck ecotypes in Nigeria. Egypt Poult Sci 31:429-436
141. Guo Y, Hastle T, Tibshirani R (2005) Regularized discriminant analysis and its application in microarrays. Biostatistics 1:1-18
142. Wernecke KD (2007) Clustering with parameters from blood tests. Wiley encyclopedia of clinical trials. Wiley, London
143. Wernecke KD (2007) Diagnosis of neuroborreliosis burgdorferi. Wiley encyclopedia of clinical trials. Wiley, London
144. Feigner JP, Sverdlov L (2001) The use of discriminant analysis to separate a study population by treatment subgroups in a clinical trial with a new pentapeptide antidepressant. J Appl Res 21:1-6
145. Adams KM (1979) Linear discriminant analysis in clinical neuropsychology. J Clin Neuropsychol 1:259-272
146. Glasson MJ, Stapleton F, Keay L, Sweeney D, Willcox MD (2003) Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers. Invest Ophthalmol Vis Sci 44:5116-5124
147. Fens N, Zwinderman AH, Van Der Schee MP, De Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180:1076-1082
148. SPSS Statistical Software. www.spss.com
149. Anonymous (2012) Cluster analysis. http://en. wikipedia.org/Clustert-analysis. Accessed 12 July 2012
150. Anonymous (2012) Sequence clustering. http://en. wikipedia.org/wiki/Sequence-analysis. Accessed 12 July 2012
151. Barthelemew DJ (1995) Spearman and the origin and development of factor analysis. Br J Math Stat Psychol 48:211-220
152. Tsao DA, Chang HJ, Hsiung SK, Huang SE, Chang MS, Chiu HH, Chen YF, Cheng TL, Shiu-Ru L (2010) Gene expression profiles for predicting the efficacy of the anticancer drug 5-fluorouracil in breast cancer. DNA Cell Biol 29:285-293
153. Latan MS, Laddha NC, Latani J, Imran MJ, Begum R, Misra A (2012) Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis. Drug Deliv Transl Res 2:129-141
154. Albertin PS (1999) Longitudinal data analysis (repeated measures) in clinical trials. Stat Med 18:2863-2870
155. Yang X, Shen Q, Xu H, Shoptaw S (2007) Functional regression analysis using an F test for longitudinal data with large numbers of repeated measures. Stat Med 26:1552-1566
156. Sverdlov L (2001) The fastclus procedure as an effective way to analyze clinical data. In: SUGI proceedings 26, paper 224, Long Beach, CA
157. Anderson TW (1990) Two of Harold Hotelling's contributions to multivariate analysis. Technical report no. 40. National Science Foundation Grant DMS 89-04851
158. Naylor MG, Lin X, Weiss ST, Raby BA, Lange C (2010) Using canonical correlation analysis to discover genetic regulatory variants. PLoS One 5(5):e10395
159. Waaijenberg S, Zwinderman AH (2007) Penalized canonical correlation analysis to quantify the association between gene expression and DNA markers. BMC Proc 1(Suppl 1):S122-S125
160. Alonso A, Geys H, Molenberghs G, Kenward MG, Vangeneugden T (2004) Validation of surrogate markers in multiple randomized clinical trails with repeated measurements, Canonical correlation approach. Biometrics 60:845-853
161. Meredith W, Tisak J (1982) Canonical analysis of longitudinal and repeated measures data with stationary weights. Psychometrika 47:47-67
162. SPSS statistical software. www.spss.com. 12 June 2012
163. Sun L, Ji S, Yu S, Ye J (2009) On the equivalence between canonical correlation analysis and orthonormalized partial least squares. In: Proceedings of conference on artificial intelligence 2009, AAAI (Association Advancement Artificial Intelligence) Publications, Palo Alto, CA, pp 1230-1235
164. Zou H, Hastie T (2005) Regularization and variable selection via the elastic net. J Roy Stat Soc B 67:301-320
165. Tibshirani R (1996) Regression shrinkage and selection via the lasso. J Roy Stat Soc B 58:267-288
166. Stevens J (1986) Applied multivariate statistics for social sciences. Erlbaum, Hillsdale
167. Zadeh LA (1965) Fuzzy sets. Inf Control 8:338-353
168. Hirota K (1993) Subway control. In: Hirota (ed) Industrial applications of fuzzy technology. Springer, Tokyo, pp 263-269
169. Fournier C, Castelain B, Coche-Dequeant B, Rousseau J (2003) MRI definition of target volumes using logic metho for three-dimensional conformal radiation therapy. Int J Rad Oncol 55:225-233
170. Catto JW, Linckens DA, Abbod MF, Chen M, Burton JL, Feeley KM, Hamdy FC (2003) Artificial intelligence in predicting bladder cancer outcome: a comparison of fuzzy modelling and artificial intelligence. Clin Cancer Res 9:4172-4177
171. Bates JH, Young MP (2003) Applying fuzzy logic to medical decision making in the intensive care. Am J Resp Crit Care Med 167:948-952
172. Caudrelier JM, Vial S, Gibon D, Kulik C, Swedko P, Boxwala A (2004) An authoring tool for fuzzy logic based decision support systems. Medinfo 9:1874-1879
173. Naranjo CA, Bremmer KE, Bazoon M, Turksen IB (1997) Using fuzzy logic to predict response to citalopram in alcohol dependence. Clin Pharmacol Ther 62:209-224
174. Helgason CM, Jobe TH (2005) Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients. Curr Treat Options Cardiol Med 7:211-218
175. Helgason CM (2004) The application of fuzzy logic to the prescription of antithrombotic agents in the elderly. Drugs Aging 21:731-736
176. Russo M, Santagati NA (1998) Medicinal chemistry and fuzzy logic. Inf Sci 105:299-314
177. SPSS Statistical Software (2010) www.SPSS.com. Accessed 22 Oct. 2010
178. Ross J (2004) Fuzzy logic with engineering applications, 2nd edn. Wiley, Chichester
179. SAS Statistical Software (2010) www.SAS.com. Accessed 22 Oct. 2010
180. FuzzyLogic (2010) fuzzylogic.sourceforge.net. Accessed 22 Oct. 2010
181. Fuzzy logic: flexible environment for exploring fuzzy systems (2010) www.wolfram.com. Accessed 22 Oct. 2010
182. Defuzzification methods. www.mathworks.com. Accessed 22 Oct. 2010